I agree gc2 that the technology can seriously help. I didnt mean to come after you. I just want to make sure I wasn't missing anything. From my research I still think we will not hear anything regarding approval until q1-q2 2020. That projection could change depending on where CVR is at with their clinical trials/data and initial application submission. The process unfortunately is so long, some people may prefer to invest elsewhere. I will be keeping my eye on cvr and this forum. GLTA.
News 
Market Data 
Discover 
